TVTX Bears Ease as Analysts Lift Targets Into Q2 Print

TVTX heads into its August 6 earnings print with short sellers retreating and analysts raising targets — a rare alignment of two signals pointing in the same direction.

Short interest has declined meaningfully over the past month, falling roughly 10.5% to 13.4% of free float, after peaking near 14 million shares in late June. The step-down was decisive: shorts dropped by about 680,000 shares in a single week in mid-July and have held steady near 12 million since. Borrow conditions reinforce the picture — cost to borrow is a negligible 0.44%, and availability remains exceptionally loose at nearly 3,000%, meaning the lending pool is far from stressed. Options positioning is neutral rather than defensive: the put/call ratio of 0.47 is almost exactly in line with its 20-day average, with a z-score near zero, giving no directional read on how options traders are positioned into the report.

Analysts have been consistently upgrading their view on the stock for months. Canaccord Genuity lifted its target to $62 on July 30 — just days ahead of the print — while Guggenheim, Wedbush, Evercore, Citigroup, and Wells Fargo all raised targets through June and early July. The consensus mean target of $59.14 sits modestly above the current price of $56.02, implying roughly 5% upside from here. Bulls point to Filspari's growing traction in the IgAN market and an FDA approval runway that provides near-term commercial protection. Bears counter that competition in both IgAN and FSGS is intensifying, and that commercial execution risk remains real — the stock's prior earnings reaction in May, a 4.8% one-day drop followed by a further drift, is a reminder that strong fundamentals do not guarantee a clean print.